Anti–factor Xa activity assays of direct‐acting oral anticoagulants during clinical care: An observational study

BACKGROUND: Direct‐acting oral anticoagulants (DOACs) are increasingly used to prevent and treat thromboembolism. Although measurement of DOAC concentrations is not currently recommended as part of routine patient care, measurement of DOAC concentrations with anti–factor Xa activity assays have rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukumar, Smrithi, Cabero, Melissa, Tiu, Sharon, Fang, Margaret C., Kogan, Scott C., Schwartz, Janice B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114026/
https://www.ncbi.nlm.nih.gov/pubmed/34013157
http://dx.doi.org/10.1002/rth2.12528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114026/
https://www.ncbi.nlm.nih.gov/pubmed/34013157
http://dx.doi.org/10.1002/rth2.12528

Ejemplares similares